Charles P. Venditti, MD
Dr. Venditti is a Senior Investigator in the National Human Genome Research Institute and the Director of the Organic Acid Research Section at the National Institutes of Health in Bethesda, MD. He graduated from MIT then attended Penn State University on an MD, PhD scholarship. After medical school graduation, Dr Venditti completed a pediatrics residency at Massachusetts General Hospital/Harvard Medical School then a combined clinical and biochemical genetics fellowship at the Children’s Hospital of Philadelphia/University of Pennsylvania School of Medicine. Immediately after fellowship, Dr Venditti joined the faculty of the NHGRI. With an outstanding group of clinical and laboratory colleagues, he has developed a translational research program to study the natural history and clinical phenotype(s) of the hereditary methylmalonic acidemias (MMA), cobalamin metabolic disorders, and propionic acidemia (PA), grave conditions that mainly affect infants and children. The clinical research is conducted in parallel with laboratory investigations that are focused on the genetics, genomics and pathophysiology of organic acid metabolism in model organisms, including zebrafish and mice. His group is also developing gene, cell and small molecules therapies to treat MMA and PA.
Dr Venditti has received a number of national and international accolades, including a Presidential Early Career Award for Scientists and Engineers (PECASE), the US Government’s highest honor for early-career scientists. He has been recognized as a Top Young Investigator by Genome Technology Magazine and as an Outstanding New Investigator by the American Society of Gene and Cell Therapy. In 2012, he was elected into the American Society of Clinical Investigation, an honor society of physician-scientists from all medical specialties who are selected by their peers for their outstanding records of scholarly achievement in biomedical research. Dr Venditti serves on the medical advisory board of the Organic Acid Association (OAA), the Scientific Review Committee for the NHGRI Institutional Review Board, the NHGRI Animal Care and User Committee (ACUC), the Board of Tutors for the NIH Medical Research Scholars Program, the editorial boards of Molecular Therapy: Methods and Clinical Development and The Journal of Clinical Investigation Impact, and as an ad hoc reviewer for numerous local, national and international granting agencies. He has authored more than 100 peer reviewed research articles and reviews, 20 textbook chapters and is the principle inventor of 10 US patents.
Dr. Venditti serves on the advisory board of the Organic Acidemia Association.
Dr Venditti has received a number of national and international accolades, including a Presidential Early Career Award for Scientists and Engineers (PECASE), the US Government’s highest honor for early-career scientists. He has been recognized as a Top Young Investigator by Genome Technology Magazine and as an Outstanding New Investigator by the American Society of Gene and Cell Therapy. In 2012, he was elected into the American Society of Clinical Investigation, an honor society of physician-scientists from all medical specialties who are selected by their peers for their outstanding records of scholarly achievement in biomedical research. Dr Venditti serves on the medical advisory board of the Organic Acid Association (OAA), the Scientific Review Committee for the NHGRI Institutional Review Board, the NHGRI Animal Care and User Committee (ACUC), the Board of Tutors for the NIH Medical Research Scholars Program, the editorial boards of Molecular Therapy: Methods and Clinical Development and The Journal of Clinical Investigation Impact, and as an ad hoc reviewer for numerous local, national and international granting agencies. He has authored more than 100 peer reviewed research articles and reviews, 20 textbook chapters and is the principle inventor of 10 US patents.
Dr. Venditti serves on the advisory board of the Organic Acidemia Association.